https://www.eurogct.org/efpia-root-cause-unavailability-and-delay-innovative-medicines
EFPIA The root cause of unavailability and delay to innovative medicines | EuroGCT
the rootinnovative medicinesefpiacausedelay
https://www.bms.com/nl/about-us/onze-verantwoordelijkheid/EFPIADisclosureCode.html
EFPIA-Bekendmakingscode
BMS steunt non-profitorganisaties die aansluiten bij onze interessegebieden door middel van subsidies. Ontdek hoe je een aanvraag kunt indienen.
efpia
https://www.efpia.eu/news-events/the-efpia-view/statements-press-releases/efpia-response-to-european-parliament-position-on-ema-fees-regulation/
EFPIA response to European Parliament position on EMA Fees Regulation
EFPIA welcomes the adoption of the EMA Fees regulation report by the European Parliament at the July Plenary session of MEP Busoi (EPP, Romania). Speaking...
european parliamentefpiaresponsepositionema
https://cris.maastrichtuniversity.nl/en/activities/european-federation-of-pharmaceutical-industries-and-associations/
European Federation of Pharmaceutical Industries and Associations (EFPIA) Annual Meeting -...
pharmaceutical industriesannual meetingeuropeanfederationassociations
https://www.abpi.org.uk/media/news/2022/april/new-efpia-wait-indicators-launched/
New EFPIA WAIT Indicators launched
newefpiawaitindicatorslaunched
https://www.asktheeu.org/request/meeting_between_dg_trade_and_efp/response/42249/attach/html/5/Document%204%20Annex%203%20to%20the%20report%20EFPIA%20Briefing%20Document.pdf.html
Document 4 Annex 3 to the report EFPIA Briefing Document.pdf
to thedocumentannexreportefpia